Risk factors and prevention of hepatocellular carcinoma in HCV infection
- 1 December 1996
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 41 (12), 49S-55S
- https://doi.org/10.1007/bf02087876
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosisJournal of Hepatology, 1996
- HCV-associated liver cancer without cirrhosisThe Lancet, 1995
- Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalitiesHepatology, 1995
- Use of confirmatory assays for diagnosis of hepatitis C viral infection in patients with hepatocellular carcinomaJournal of Medical Virology, 1994
- Hepatitis B and C Viral Infections in Patients With Hepatocellular CarcinomaHepatology, 1992
- Antibodies to hepatitis C virus in patients with hepatocellular carcinomaJournal of Hepatology, 1991
- Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinomaThe Lancet, 1990
- PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN HEPATOCELLULAR CARCINOMAThe Lancet, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989
- Cirrhosis and the aetiology of hepatocellular carcinomaJournal of Hepatology, 1987